Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001610520-24-000140
Filing Date
2024-08-08
Accepted
2024-08-08 12:55:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4413
  Complete submission text file 0001610520-24-000140.txt   6174
Mailing Address 4040 CAMPBELL AVE, SUITE 100 MENLO PARK CA 94025
Business Address 4040 CAMPBELL AVE, SUITE 100 MENLO PARK CA 94025 (415) 889-0550
Sight Sciences, Inc. (Subject) CIK: 0001531177 (see all company filings)

EIN.: 800625749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92715 | Film No.: 241187214
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address BAHNHOFSTRASSE 45 ZURICH V8 CH-8001
Business Address BAHNHOFSTRASSE 45 ZURICH V8 CH-8001 41-44-234-1111
UBS Group AG (Filed by) CIK: 0001610520 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6021 National Commercial Banks
(CF Office: 02 Finance)